BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27789412)

  • 1. Characterization of dermal fibroblast-derived iPSCs from a patient with high grade steatosis.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):568-571. PubMed ID: 27789412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of iPSCs derived from dermal fibroblasts from a healthy 19year old female.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):597-599. PubMed ID: 27934589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of dermal fibroblast-derived iPSCs from a patient with low grade steatosis.
    Kawala MA; Bohndorf M; Graffmann N; Wruck W; Zatloukal K; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):547-549. PubMed ID: 27789406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and characterization of two iPSC lines from human epicardium-derived cells.
    Paulitschek C; Schulze-Matz P; Hesse J; Schmidt T; Wruck W; Adjaye J; Schrader J
    Stem Cell Res; 2017 Apr; 20():50-53. PubMed ID: 28395740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
    Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
    Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cells (iPSCs) stably expressing CRISPR-based synergistic activation mediator (SAM).
    Xiong K; Zhou Y; Hyttel P; Bolund L; Freude KK; Luo Y
    Stem Cell Res; 2016 Nov; 17(3):665-669. PubMed ID: 27934604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphoblast-derived integration-free iPSC lines from a female and male Alzheimer's disease patient expressing different copy numbers of a coding CNV in the Alzheimer risk gene CR1.
    Schröter F; Sleegers K; Van Cauwenberghe C; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):560-563. PubMed ID: 27789410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
    Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
    Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
    Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
    Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of induced pluripotent stem cell line from foreskin fibroblasts.
    Skrzypczyk A; Giri S; Bader A
    Stem Cell Res; 2016 Nov; 17(3):572-575. PubMed ID: 27789413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishment of induced pluripotent stem cell (iPSC) line from 55-year old male patient with hemorrhagic Moyamoya disease.
    Cardano M; Marsoner F; Marcatili M; Karnavas T; Zasso J; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):623-626. PubMed ID: 27934594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
    Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
    Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation and characterization of an induced pluripotent stem cell (iPSC) line from a patient with clozapine-resistant Schizophrenia.
    Marsoner F; Marcatili M; Karnavas T; Bottai D; D'Agostino A; Scarone S; Conti L
    Stem Cell Res; 2016 Nov; 17(3):661-664. PubMed ID: 27934603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of Induced Pluripotent Stem Cells (iPSCs) from Adult Canine Fibroblasts.
    Koh S; Piedrahita JA
    Methods Mol Biol; 2015; 1330():69-78. PubMed ID: 26621590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lymphoblast-derived integration-free iPS cell line from a female 67-year-old Alzheimer's disease patient with TREM2 (R47H) missense mutation.
    Schröter F; Sleegers K; Cuyvers E; Bohndorf M; Wruck W; Van Broeckhoven C; Adjaye J
    Stem Cell Res; 2016 Nov; 17(3):553-555. PubMed ID: 27789408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation of induced pluripotent stem cells from orangutan skin fibroblasts.
    Ramaswamy K; Yik WY; Wang XM; Oliphant EN; Lu W; Shibata D; Ryder OA; Hacia JG
    BMC Res Notes; 2015 Oct; 8():577. PubMed ID: 26475477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of human iPSCs from an essential thrombocythemia patient carrying a V501L mutation in the MPL gene.
    Liu S; Ye Z; Gao Y; He C; Williams DW; Moliterno A; Spivak J; Huang H; Cheng L
    Stem Cell Res; 2017 Jan; 18():57-59. PubMed ID: 28395806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of induced pluripotent stem cell (iPSC) line from an 8-year old female patient with ischemic Moyamoya disease.
    Cardano M; Marsoner F; Zasso J; Marcatili M; Karnavas T; Lanterna LA; Conti L
    Stem Cell Res; 2016 Nov; 17(3):619-622. PubMed ID: 27934593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inducing Pluripotency in Cattle.
    Malaver-Ortega LF; Taheri-Ghahfarokhi A; Sumer H
    Methods Mol Biol; 2015; 1330():57-68. PubMed ID: 26621589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.